Home/Filings/4/0001493152-22-026230
4//SEC Filing

O'Brien Sarah 4

Accession 0001493152-22-026230

CIK 0001695357other

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 4:07 PM ET

Size

5.8 KB

Accession

0001493152-22-026230

Insider Transaction Report

Form 4
Period: 2022-09-15
O'Brien Sarah
Chief People Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-09-15+100,000100,000 total
    Exercise: $5.35Exp: 2032-09-15Common Stock, par value $0.0001 (100,000 underlying)
Footnotes (2)
  • [F1]On September 15, 2022, the Reporting Person was granted a stock option for 100,000 shares of Common Stock which vests in four equal annual installments commencing on September 15, 2022. Reporting Person was also granted 100,000 stock options under the Issuer's 2020 Inducement Plan, as amended, with performance-based vesting triggers that will be reported, if and when vested, consistent with the applicable reporting requirements.
  • [F2]The stock options were granted pursuant to the Issuer's 2020 Inducement Plan, as amended.

Documents

1 file

Issuer

Provention Bio, Inc.

CIK 0001695357

Entity typeother

Related Parties

1
  • filerCIK 0001946781

Filing Metadata

Form type
4
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:07 PM ET
Size
5.8 KB